Chinese consumers tap the fintech app to pay bills, order in restaurants, and book appointments. Now it’s preparing for an IPO that could value it at $200 billion. https://bit.ly/2ZT5guW
By early 2024, a tablet called Opill will be sold in pharmacies without a prescription, making it easier for uninsured and young buyers to access. https://www.wired.com/story/fda-approves-over-the-counter-birth-control-pill-heres-what-to-know/?utm_source=dlvr.it&utm_medium=blogger